SEC Comment Letter for MANNKIND CORP (MNKD) (CIK 0000899460) (MNKD) — Jul 11, 2017
MANNKIND CORP (MNKD) (CIK 0000899460)
Date: July 11, 2017 · CIK: 0000899460 · Accession: 0000000000-17-024195
AI Filing Summary & Sentiment
Reasoning
Letter
July 10, 2017 Michael E. Castagna Chief Executive Officer Mannkind Corporation 25134 Rye Canyon Loop, Suite 300 Valencia, CA 91355 Mannkind Corporation Registration Statement on Form S-1 Filed July 3, 2017 File No. 333-219136Re: Dear Mr. Castagna: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Christine Westbrook at (202) 551-5019 with any questions. Division of Corporation Finance Office of Healthcare and Insurance cc: Asa Henin, Esq.
Show Raw Text
July 10, 2017
Michael E. Castagna
Chief Executive Officer
Mannkind Corporation
25134 Rye Canyon Loop, Suite 300
Valencia, CA 91355
Mannkind Corporation
Registration Statement on Form S-1
Filed July 3, 2017
File No. 333-219136Re:
Dear Mr. Castagna:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Christine Westbrook at (202) 551-5019 with any questions.
Division of Corporation Finance
Office of Healthcare and
Insurance
cc: Asa Henin, Esq.